Showing results (1-10 of 462) with videos related to
Sort By:
Pageof 47
European Neurology|March 25, 2010
When do levodopa motor fluctuations first appear in Parkinson's disease?Fabrizio Stocchi, Peter Jenner, Jose A ObesoThe Lancet. Neurology|July 22, 2006
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implicationsC Warren Olanow, Jose A Obeso, Fabrizio StocchiJournal of Neurology|May 12, 2011
Continuous dopaminergic stimulation and novel formulations of dopamine agonistsFabrizio StocchiJournal of Neurology|October 14, 2005
Optimising levodopa therapy for the management of Parkinson's diseaseFabrizio StocchiExpert Opinion on Pharmacotherapy|June 30, 2006
The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerationsFabrizio StocchiNeuro-Degenerative Diseases|March 13, 2010
The concept of continuous dopaminergic stimulation: what we should consider when starting Parkinson's disease treatmentFabrizio StocchiNeurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 22, 2009
Use of apomorphine in Parkinson's diseaseFabrizio StocchiParkinsonism & Related Disorders|August 14, 2003
Prevention and treatment of motor fluctuationsFabrizio StocchiParkinsonism & Related Disorders|February 4, 2010
Dopamine receptor agonists in the treatment of advanced Parkinson's diseaseFabrizio StocchiParkinsonism & Related Disorders|January 10, 2009
The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's diseaseFabrizio StocchiPageof 47